Literature DB >> 6660849

Effect of phosphate and amino acids on echinomycin biosynthesis by Streptomyces echinatus.

J V Formica, M J Waring.   

Abstract

Streptomyces echinatus produces only echinomycin (quinomycin A), in contrast to other streptomycetes, which produce families of quinoxaline antibiotics differing in the amino acid composition of the oligopeptide (quinomycins A, B, B0, C, D, and E) or the structure of the sulfur-containing cross bridge (triostins A, B, and C). Attempts were made to establish conditions for directed biosynthesis with S. echinatus. The lability of the peptide lactone to alkaline pH was obviated by using high levels of phosphate or HEPES [4-(2-hydroxyethyl)-1-piperazineethane-sulfonic acid] buffer in the production medium. Maintaining the pH below 7.5 resulted in an apparent stimulation of production. Amino acids which serve as structural components or as precursors of echinomycin were employed singly or in combination with nitrate in a chemically defined medium. Based on specific yield (micrograms of echinomycin per milligram of mycelia [dry weight]), D- and L-serine, D-alanine, L-valine, and L-phenylalanine produced equivalent yields of antibiotic which were approximately twofold greater than yields obtained with nitrate alone. In contrast, L-alanine, beta-alanine, and L-threonine produced a three- to fourfold stimulation of production. Although the other amino acids diminished antibiotic production, L-isoleucine, which ostensibly was inhibitory to production, supported the accumulation of a quinoxaline antibiotic in which the cross-bridge sulfur lacked a methyl group.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6660849      PMCID: PMC185935          DOI: 10.1128/AAC.24.5.735

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  12 in total

1.  Structure revision of the antibiotic echinomycin.

Authors:  A Dell; D H Williams; H R Morris; G A Smith; J Feeney; G C Roberts
Journal:  J Am Chem Soc       Date:  1975-04-30       Impact factor: 15.419

2.  Echinomycin: a bifunctional intercalating antibiotic.

Authors:  M J Waring; L P Wakelin
Journal:  Nature       Date:  1974-12-20       Impact factor: 49.962

3.  Studies on the formation of bacitracin by Bacillus licheniformis: effect of inorganic phosphate.

Authors:  H I Haavik
Journal:  J Gen Microbiol       Date:  1974-09

4.  Isolation, purification, and characterization of pipecolic acid-containing actinomycins, Pip 2, Pip 1 , and Pip 1 .

Authors:  J V Formica; E Katz
Journal:  J Biol Chem       Date:  1973-03-25       Impact factor: 5.157

Review 5.  Control of antibiotic biosynthesis.

Authors:  J F Martin; A L Demain
Journal:  Microbiol Rev       Date:  1980-06

6.  Production, isolation, and properties of azetomycins.

Authors:  J V Formica; M A Apple
Journal:  Antimicrob Agents Chemother       Date:  1976-02       Impact factor: 5.191

7.  Structure and conformation of fourteen antibiotics of the quinoxaline group determined by 1H NMR.

Authors:  M P Williamson; D Gauvreau; D H Williams; M J Waring
Journal:  J Antibiot (Tokyo)       Date:  1982-01       Impact factor: 2.649

8.  Binding of quinoline analogues of echinomycin to deoxyribonucleic acid. Role of the chromophores.

Authors:  K R Fox; D Gauvreau; D C Goodwin; M J Waring
Journal:  Biochem J       Date:  1980-12-01       Impact factor: 3.857

9.  Influence of isoleucine upon quinomycin biosynthesis by Streptomyces sp. 732.

Authors:  T Yoshida; K Katagiri
Journal:  J Bacteriol       Date:  1967-04       Impact factor: 3.490

10.  Interaction between synthetic analogues of quinoxaline antibiotics and nucleic acids. Changes in mechanism and specificity related to structural alterations.

Authors:  J S Lee; M J Waring
Journal:  Biochem J       Date:  1978-07-01       Impact factor: 3.857

View more
  2 in total

1.  Negative regulation of human growth hormone gene expression by insulin is dependent on hypoxia-inducible factor binding in primary non-tumor pituitary cells.

Authors:  Hana Vakili; Yan Jin; Peter A Cattini
Journal:  J Biol Chem       Date:  2012-07-25       Impact factor: 5.157

Review 2.  Hypoxia inducible factor pathway inhibitors as anticancer therapeutics.

Authors:  Erwin G Van Meir; Binghe Wang; Sarah K Burroughs; Stefan Kaluz; Danzhu Wang; Ke Wang
Journal:  Future Med Chem       Date:  2013-04       Impact factor: 3.808

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.